Interpace Biosciences Inc (IDXG)
1.45
0.00 (0.00%)
USD |
OTCM |
Apr 22, 16:00
Interpace Biosciences Revenue (TTM): 39.47M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 39.47M |
| June 30, 2023 | 37.37M |
| March 31, 2023 | 33.74M |
| December 31, 2022 | 31.84M |
| September 30, 2022 | 32.62M |
| June 30, 2022 | 32.49M |
| March 31, 2022 | 36.25M |
| December 31, 2021 | 38.16M |
| September 30, 2021 | 38.69M |
| June 30, 2021 | 38.88M |
| March 31, 2021 | 33.17M |
| December 31, 2020 | 32.40M |
| September 30, 2020 | 26.97M |
| June 30, 2020 | 26.44M |
| March 31, 2020 | 27.27M |
| December 31, 2019 | 24.22M |
| September 30, 2019 | 25.84M |
| June 30, 2019 | 23.87M |
| March 31, 2019 | 23.10M |
| December 31, 2018 | 21.90M |
| September 30, 2018 | 20.43M |
| June 30, 2018 | 18.88M |
| March 31, 2018 | 17.24M |
| December 31, 2017 | 15.90M |
| September 30, 2017 | 14.65M |
| Date | Value |
|---|---|
| June 30, 2017 | 13.76M |
| March 31, 2017 | 13.52M |
| December 31, 2016 | 13.08M |
| September 30, 2016 | 12.52M |
| June 30, 2016 | 11.71M |
| March 31, 2016 | 10.35M |
| December 31, 2015 | 9.432M |
| September 30, 2015 | -82.75M |
| June 30, 2015 | -57.00M |
| March 31, 2015 | -28.24M |
| December 31, 2014 | 1.474M |
| September 30, 2014 | 123.21M |
| June 30, 2014 | 129.21M |
| March 31, 2014 | 135.44M |
| December 31, 2013 | 146.53M |
| September 30, 2013 | 150.06M |
| June 30, 2013 | 147.58M |
| March 31, 2013 | 138.14M |
| December 31, 2012 | 126.90M |
| September 30, 2012 | 129.55M |
| June 30, 2012 | 133.84M |
| March 31, 2012 | 144.67M |
| December 31, 2011 | 157.29M |
| September 30, 2011 | 153.64M |
| June 30, 2011 | 153.55M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
23.87M
Minimum
Jun 2019
39.47M
Maximum
Dec 2023
32.20M
Average
32.55M
Median
Revenue (TTM) Benchmarks
| Fonar Corp | 102.42M |
| XWELL Inc | 30.11M |
| ProPhase Labs Inc | 44.38M |
| Applied DNA Sciences Inc | 8.996M |
| Veracyte Inc | 361.05M |